Drug Shortage Report for TEVA-CILAZAPRIL/HCTZ

Last updated on 2021-02-25 History
Report ID 126948
Drug Identification Number 02313731
Brand name TEVA-CILAZAPRIL/HCTZ
Common or Proper name CILAZAPRIL/HCTZ 5/12.5MG TAB
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) CILAZAPRIL HYDROCHLOROTHIAZIDE
Strength(s) 5MG 12.5MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging size 100
ATC code C09BA
ATC description ACE INHIBITORS, COMBINATIONS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2020-10-21
Estimated end date 2021-04-30
Actual end date
Shortage status Actual shortage
Updated date 2021-02-25
Company comments
Health Canada comments
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v8 2021-02-25 French Compare
v7 2021-02-25 English Compare
v6 2021-01-28 French Compare
v5 2021-01-28 English Compare
v4 2021-01-07 French Compare
v3 2021-01-07 English Compare
v2 2020-10-22 French Compare
v1 2020-10-22 English Compare